🇺🇸 FDA

Intelligence Platform

Patents

Browse 111 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10912771

Methods for the administration of certain VMAT2 inhibitors

Neurocrine Biosciences, Inc. · Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10905690

Treatment of congenital adrenal hyperplasia

Neurocrine Biosciences, Inc. · Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10874648

Methods for the administration of certain VMAT2 inhibitors

Neurocrine Biosciences, Inc. · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10857148

Methods for the administration of certain VMAT2 inhibitors

Neurocrine Biosciences, Inc. · Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10857137

Methods for the administration of certain VMAT2 inhibitors

Neurocrine Biosciences, Inc. · Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10851104

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10851103

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. · Granted Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10844058

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. · Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10738017

Substituted triazoles and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494347

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10336769

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10138214

Substituted triazoles and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10065952

Valbenazine salts and polymorphs thereof

Neurocrine Biosciences, Inc. · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9988382

[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquinolin-2-yl]m

Neurocrine Biosciences, Inc. · Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868706

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9782398

Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and use

Neurocrine Biosciences, Inc. · Granted Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9718789

Substituted triazoles and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9714246

[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquinolin-2-yl]m

Neurocrine Biosciences, Inc. · Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422310

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9382214

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8952161

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8765948

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507536

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481731

Compounds, pharmaceutical composition and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted